Before joining Newable, Sanjeev Gordhan worked on the advisory side of the industry. He has a lot of experience in helping investors decide how much money to put into venture capital and unquoted investments.
In this episode of The EIS Navigator, Brian and Sanjeev discuss how investors should approach this choice and the difference between theory and practice. They also get into how you should spread your venture capital allocation between different segments, discussing how risk and value interact. And of course, they can’t ignore COVID and how investors are reacting to it in their portfolios.
Please email [email protected] if you have any questions or comments on The EIS Navigator.
Never miss an episode – click here to subscribe to The EIS Navigator on most popular services.
Read Hardman & Co’s latest investment research on Newable funds here.
Visit the Newable website here.
21 Lessons for the 21st Century by Yuval Noah Harari
The Chimp Paradox by Prof Steven Peters
Sanjeev Gordhan joined Newable Ventures in December 2018 and is responsible for the strategic focus of the fund and angel network and its day-to-day management. Sanjeev started as an entrepreneur before going onto selling his own business, and spent five years as a Wealth Manager specialising in venture capital. He holds a diploma in Regulated Financial Planning and an MBA from CASS Business School.
Disclaimer
Please note this podcast/interview does not constitute a financial promotion and is provided for informational purposes and should not be construed as an invitation or offer to buy or sell any investments. Please be aware that investments into unquoted companies are high risk, long term and illiquid investments. Your capital is at risk. Past performance is not a reliable indicator of future performance. Target returns are not guaranteed and forward looking statements are illustrative only and must not be relied upon. Investors should only invest on the basis of reading the full offer documentation. Listeners must make their own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein.
